Why the study?
To describe the rare condition of Shone complex, its pathophysiology, and methods for early diagnosis.
Highlights the importance of considering complex congenital heart defects like Shone syndrome in young patients presenting with treatment-resistant hypertension.
Case of adult Shone complex with refractory hypertension warrants individualized surveillance; leaves open prospective data on optimal therapy.
INTRODUCTION: and importance: Shone complex is a congenital heart defect consisting of four obstructive defects in the left heart: a mitral supravalvular ring, sub-aortic stenosis, parachute mitral valve, and coarctation of the aorta (CoA), which affects only a small minority of people. CASE PRESENTATION: We report the case of a 25-year-old woman with a past medical history of moderate mitral stenosis, since she was 10-year-old with uncontrolled high blood pressure, treated with nicardipine. admitted to our emergency department with high blood pressure: 190/80 mmhg, in whom The transthoracic echocardiography (TTE) revealed: sub-mitral membrane, with a single sub-papillary muscle, and coarctation of the aorta and the CT scan showed narrowed aortic arch and a left superior vena cava allowing to retain shone syndrome as the main diagnosis. The patient was treated with an antihypertensive treatment combining (perindopril/indapamide/amlodipine) while waiting for surgery. CLINICAL DISCUSSION: In this mini-review, we aim to describe this rare pathological condition its pathophysiological thoughts, and the way to diagnosis this complex early. CONCLUSION: Treatment required the coordinated efforts of a team of specialists. It could be either surgical with different method or by Trans catheter treatments.
No takes yet. Share an insight, caveat, or question.
Boulouiz et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: